510(k) Report

510(k) · Cleared

Cleared

Hemosil F11 & FV Dna Control

K093737510(k) TraditionalCleared May 4, 2010151-day reviewClass II21 CFR 866.5910

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Instrumentation Laboratory CO · NZB Quality Control Material, Genetics, Dna

Cleared on May 4, 2010 as substantially equivalent to K083171 (Maine Molecular Quality Controls, Inc., 2008) after a 151-day review. Its family tree reaches back 1 generation to 2008.

Decided
May 4, 2010
Review
151 days
Class
Class II
Product code
NZB
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K083171 (2008). No later device cites it as a predicate yet.

K083171 · Introl CF Panel I Control, Model: G106 · Maine Molecular Quality Controls, Inc. · 20082006200820102012
  1. Root · 1 generation backK083171 Introl CF Panel I Control, Model: G106Maine Molecular Quality Controls, Inc. · 2008
  2. This deviceK093737 Hemosil F11 & FV Dna ControlInstrumentation Laboratory CO · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K083171Introl CF Panel I Control, Model: G106Maine Molecular Quality Controls, Inc.2008—
0 (this device)K093737Hemosil F11 & FV Dna ControlInstrumentation Laboratory CO2010—
FIG. 1 — Lineage of K093737, 2008–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NZB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K083171Introl CF Panel I Control, Model: G106
Summary page 1
…tion Name: Quality Control, Genetics, DNA Regulatory Class: Class II Product Code: NZB Panel: Immunology (82) Predicate Device: K083 171 INTROLTM CF Panel I Control Device Description: HemnosiL ElI & FV DNA Control is synthetic Factor II and Facto…
Maine Molecular Quality Controls, Inc.2008—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All NZB devices

NZB Quality Control Material, Genetics, Dna: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · NZB

1in 2010

2008: 12010: 1
2007high 1 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NZB

Too few NZB 510(k)s in any year since 2007 to give a median.

Recalls per year · NZB

No recall names NZB since 2007.

Adverse event reports per year · NZB

No MAUDE report names NZB since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—00
20090—00
20101—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

HemosIL FII & FV DNA Control is intended for in vitro diagnostic use as a heterozygous quality control to monitor analytical performance of the extraction, amplification and detection steps of the Xpert HemosIL FII & FV genotyping assay on the GeneXpert® Dx System used in the detection of both the Factor II 20210G>A and Factor V 1691G>A (Leiden) mutations.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K093737: Hemosil F11 & FV Dna Control.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K093737

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026